BioNTech SE BNTX
NASDAQ BNTX
$96.90 +0.05 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Return on Sales [ROS] (2018 - 2026)

Updated

BioNTech SE (BNTX) reported Return on Sales [ROS] of -897.82% for Q2 2026, down 705.68 percentage points from -192.14% a year earlier and down 324.16 percentage points from the prior quarter.

Analysis

BioNTech SE (BNTX) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, BioNTech SE's Return on Sales [ROS] came in at -75.20%, down 44.53 percentage points year-over-year; for FY2025, it was -48.95%, down 1.18 percentage points from FY2024.

  • Return on Sales [ROS] has declined for four consecutive years, with a five-year change of -31.87 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -47.77% in FY2024 (-65.85 pp), 18.08% in FY2023 (-54.96 pp), 73.03% in FY2022 (-7.51 pp) and 80.54% in FY2021 (+97.62 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q3 2018.
  • Year over year, Return on Sales [ROS] has now declined in each of the last four quarters, with an average year-over-year change of -66.60 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2025 (a gain of 558.60 percentage points); the low point was Q2 2026 (a drop of 705.68 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -573.67% (Q1 2026), -35.57% (Q4 2025) and -3.09% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 BioNTech SE 24.50 Bn -34.86 Bn 10.00 Mn -897.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -897.82%
Mar 31, 2026 -573.67%
Dec 31, 2025 -35.57%
Sep 30, 2025 -3.09%
Jun 30, 2025 -192.14%
Mar 31, 2025 -292.18%
Dec 31, 2024 12.49%
Sep 30, 2024 0.84%
Jun 30, 2024 -750.74%
Mar 31, 2024 -270.36%
Dec 31, 2023 35.58%
Sep 30, 2023 8.16%
Jun 30, 2023 -335.90%
Mar 31, 2023 51.25%
Dec 31, 2022 76.97%
Sep 30, 2022 68.98%
Jun 30, 2022 69.13%
Mar 31, 2022 74.56%
Dec 31, 2021 84.95%
Sep 30, 2021 77.60%
API Access

BioNTech SE Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BNTX&period=max&api_key=YOUR_API_KEY